Detail
| LncRNA Name | SAP30L-AS1 |
| Synonyms | NA, FLJ38109, GALNT10-AS1 |
| Region | GRCh38_5:154329437-154445850 Sequence |
| Ensembl | ENSG00000245275 |
| RefSeq | NR_037897 |
| Circulating | ✔ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | qPCR, Western blot |
| Sample | cell line (LNCaP) |
| Expression Pattern | up-regulated |
| Function Description | The levels of SAP30L-AS1 were upregulated in benign prostatic hyperplasia (BPH).SAP30L-AS1 and SChLAP1 had adequate diagnostic value to distinguish PCa from controls. Two lncRNAs separately combined with prostate specific antigen (PSA) possessed a moderate ability for discrimination.SAP30L-AS1 expression level was related to PSA values and tumor invasion,may lead to the identification of suitable biomarkers, with potential diagnostic utility |
| Pubmed ID | 29614511 |
| Year | 2018 |
| Title | Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer. |
| External Links |
| Links for SAP30L-AS1 | GenBank HGNC lncrnadb Noncode |
| Links for prostate cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.